Strekin is privately funded by a broad base of investors including current and former Senior Executives from Biotech and Pharma.  Strekin has the opportunity to tap into this vast expertise. 

The company is sufficiently funded to achieve the next major corporate milestones.

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.